Company Filing History:
Years Active: 2013
Title: Rameh Hafezi: Innovator in Cancer Treatment
Introduction
Rameh Hafezi is a notable inventor based in Franklin Park, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of biomarkers.
Latest Patents
Hafezi holds a patent for "Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators." This patent outlines the use of IGF1R biomarkers in identifying and monitoring mammals that will respond therapeutically to cancer treatments involving IGF1R modulators. The method includes exposing the mammal to the modulator and measuring the biomarker levels to determine therapeutic responses.
Career Highlights
Rameh Hafezi is currently employed at Bristol-Myers Squibb Company, where he continues to advance his research in cancer therapies. His work focuses on developing methods that enhance the effectiveness of treatments for patients.
Collaborations
Hafezi collaborates with esteemed colleagues, including Fei Huang and Xia Han, to further his research and innovation in the field of oncology.
Conclusion
Rameh Hafezi's contributions to cancer treatment through his patented innovations and collaborative efforts highlight his commitment to improving therapeutic outcomes for patients. His work exemplifies the impact of scientific research on healthcare advancements.